Development of a Partograph E-learning Tool and Evaluation of Its Efficiency in Student Midwives

NCT05909306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2023-06-22

No results posted yet for this study

Summary

A randomized control trial was made to develop a partograph e-learning tool and evaluate its effectiveness in student midwives in Turkey.

Conditions

  • Midwifery Students Education

Interventions

OTHER

Education Group

Two online meetings were planned with the education group. In the first meeting, an average of 35-minute-long live lecturing was performed on filling out the data forms and using the partograph e-learning tool through e-learning tool created in the first interview. The researcher held the second interview one week after the first one. In the second interview, a live lecture lasting 30 minutes was given to talk about and solve the problems that students experienced with the partograph e-learning tool and answer the questions. The partograph e-learning tool was kept open for one month for the students in the education group. At the end of the one-month education, the students were asked to fill out the post-test (Academic Achievement Test) defined in the system. After the post-test was completed, the system was closed to the access of the students in the education group and made available to the students in the control group.

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Damla Kizilca Cakaloz, PhD · Adnan Menderes University, Faculty of Health Sciences, Division of Midwifery

  • Ayden Coban, PhD · Adnan Menderes University, Faculty of Health Sciences, Division of Midwifery

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-10-28
Completion
2021-10-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05909306 on ClinicalTrials.gov